Concepedia

Marc F. DeCristofaro

MF

7

Publications

534

Citations

7

H-Index

1999

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

University of North Carolina at Chapel Hill

UNC Lineberger Comprehensive Cancer Center

University of Cincinnati Medical Center

Marc F. DeCristofaro is an author at Novartis (Switzerland) specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

1999–2017

7

Publications

7

BRG-1 is required for RB-mediated cell cycle arrest

Matthew W. Strobeck, Karen E. Knudsen, Anne F. Fribourg et al. · Proceedings of the National Academy of Sciences · 2000 · 246 citations

, , +13

The BRG-1 Subunit of the SWI/SNF Complex Regulates CD44 Expression

Matthew W. Strobeck, Marc F. DeCristofaro, Fatima Banine et al. · Journal of Biological Chemistry · 2001 · 92 citations · Full text

Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors

Marc F. DeCristofaro, Bryan L. Betz, Weidong Wang et al. · Oncogene · 1999 · 86 citations

, , +9

The effect of angiotensin receptor neprilysin inhibitor, sacubitril/valsartan, on central nervous system amyloid-β concentrations and clearance in the cynomolgus monkey

Heidi A. Schoenfeld, Tim West, Philip B. Verghese et al. · Toxicology and Applied Pharmacology · 2017 · 44 citations · Full text

Investigation of Correlation Among Safety Biomarkers in Serum, Histopathological Examination, and Toxicogenomics

Tao Wang, Maria Papoutsi, Marion Wiesmann et al. · International Journal of Toxicology · 2011 · 35 citations

, , +25

Rows per page

1–5 of 7